Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TUBA1C |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → TUBA1C |
| (<<) ALDOA → TUBA1C |
| (<<) SET → TUBA1C |
| (<<) ST3GAL6 → TUBA1C |
| (<<) TUBA1B → TUBA1C |
| Downstream (Children) |
|---|
| TUBA1C → BAALC (>>) |
| TUBA1C → CCNB1 (>>) |
| TUBA1C → CDK4 (>>) |
| TUBA1C → CENPF (>>) |
| TUBA1C → CFL1 (>>) |
| TUBA1C → DPH2 (>>) |
| TUBA1C → DYNLL1 (>>) |
| TUBA1C → MAT2A (>>) |
| TUBA1C → MMP1 (>>) |
| TUBA1C → NOL9 (>>) |
| TUBA1C → PHLDA2 (>>) |
| TUBA1C → PKM2 (>>) |
| TUBA1C → PPRC1 (>>) |
| TUBA1C → RBL2 (>>) |
| TUBA1C → SLC26A1 (>>) |
| TUBA1C → TRIM32 (>>) |
| TUBA1C → TSPAN3 (>>) |
| TUBA1C → TUBB2C (>>) |
| TUBA1C → UBE2N (>>) |
| TUBA1C → VPS37B (>>) |
